194 related articles for article (PubMed ID: 30562113)
1. Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.
Coats CJ; Heywood WE; Virasami A; Ashrafi N; Syrris P; Dos Remedios C; Treibel TA; Moon JC; Lopes LR; McGregor CGA; Ashworth M; Sebire NJ; McKenna WJ; Mills K; Elliott PM
Circ Genom Precis Med; 2018 Dec; 11(12):e001974. PubMed ID: 30562113
[TBL] [Abstract][Full Text] [Related]
2. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
4. Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.
Tucholski T; Cai W; Gregorich ZR; Bayne EF; Mitchell SD; McIlwain SJ; de Lange WJ; Wrobbel M; Karp H; Hite Z; Vikhorev PG; Marston SB; Lal S; Li A; Dos Remedios C; Kohmoto T; Hermsen J; Ralphe JC; Kamp TJ; Moss RL; Ge Y
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24691-24700. PubMed ID: 32968017
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
[TBL] [Abstract][Full Text] [Related]
6. Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy.
Garmany R; Bos JM; Tester DJ; Giudicessi JR; Dos Remedios CG; Dasari S; Nagaraj NK; Nair AA; Johnson KL; Ryan ZC; Maleszewski JJ; Ommen SR; Dearani JA; Ackerman MJ
Circ Genom Precis Med; 2023 Apr; 16(2):e003756. PubMed ID: 36802768
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.
Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K
Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064
[TBL] [Abstract][Full Text] [Related]
8. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy.
Rixon C; Andreassen K; Shen X; Erusappan PM; Almaas VM; Palmero S; Dahl CP; Ueland T; Sjaastad I; Louch WE; Stokke MK; Tønnessen T; Christensen G; Lunde IG
ESC Heart Fail; 2023 Apr; 10(2):858-871. PubMed ID: 36444917
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy.
Shimada YJ; Raita Y; Liang LW; Maurer MS; Hasegawa K; Fifer MA; Reilly MP
Circ Heart Fail; 2021 Jul; 14(7):e007849. PubMed ID: 34192899
[TBL] [Abstract][Full Text] [Related]
12. Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy.
Helms AS; Davis FM; Coleman D; Bartolone SN; Glazier AA; Pagani F; Yob JM; Sadayappan S; Pedersen E; Lyons R; Westfall MV; Jones R; Russell MW; Day SM
Circ Cardiovasc Genet; 2014 Aug; 7(4):434-43. PubMed ID: 25031304
[TBL] [Abstract][Full Text] [Related]
13. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
[TBL] [Abstract][Full Text] [Related]
14. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
15. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
de Feria AE; Kott AE; Becker JR
Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
[TBL] [Abstract][Full Text] [Related]
16. Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.
Nollet EE; Schuldt M; Sequeira V; Binek A; Pham TV; Schoonvelde SAC; Jansen M; Schomakers BV; van Weeghel M; Vaz FM; Houtkooper RH; Van Eyk JE; Jimenez CR; Michels M; Bedi KC; Margulies KB; Dos Remedios CG; Kuster DWD; van der Velden J
Circ Genom Precis Med; 2024 Jun; 17(3):e004369. PubMed ID: 38853772
[TBL] [Abstract][Full Text] [Related]
17. Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
Schuldt M; Pei J; Harakalova M; Dorsch LM; Schlossarek S; Mokry M; Knol JC; Pham TV; Schelfhorst T; Piersma SR; Dos Remedios C; Dalinghaus M; Michels M; Asselbergs FW; Moutin MJ; Carrier L; Jimenez CR; van der Velden J; Kuster DWD
Circ Heart Fail; 2021 Jan; 14(1):e007022. PubMed ID: 33430602
[TBL] [Abstract][Full Text] [Related]
18. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
[TBL] [Abstract][Full Text] [Related]
20. Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.
Kuusisto J; Kärjä V; Sipola P; Kholová I; Peuhkurinen K; Jääskeläinen P; Naukkarinen A; Ylä-Herttuala S; Punnonen K; Laakso M
Heart; 2012 Jul; 98(13):1007-13. PubMed ID: 22447464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
